Clinical Trials Browser

Phase 2/3 × Unknown × 130-nm albumin-bound paclitaxel × Clear all

NCT04907344 2021-05-28

Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

Phase 2/3 Unknown

Triple Negative Breast Neoplasms

NCT04435652 2020-06-17

A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.

Phase 2/3 Unknown

Gastrointestinal

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma